166 related articles for article (PubMed ID: 38281200)
21. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract][Full Text] [Related]
22. Coccidioidomycosis Detection Using Targeted Plasma and Urine Metabolic Profiling.
Jasbi P; Mitchell NM; Shi X; Grys TE; Wei Y; Liu L; Lake DF; Gu H
J Proteome Res; 2019 Jul; 18(7):2791-2802. PubMed ID: 31244214
[TBL] [Abstract][Full Text] [Related]
23. Identification of the urine and serum metabolomics signature of gout.
Huang Y; Xiao M; Ou J; Lv Q; Wei Q; Chen Z; Wu J; Tu L; Jiang Y; Zhang X; Qi J; Qiu M; Cao S; Gu J
Rheumatology (Oxford); 2020 Oct; 59(10):2960-2969. PubMed ID: 32134107
[TBL] [Abstract][Full Text] [Related]
24. Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS.
Wang R; Kang H; Zhang X; Nie Q; Wang H; Wang C; Zhou S
BMC Cancer; 2022 Feb; 22(1):214. PubMed ID: 35220945
[TBL] [Abstract][Full Text] [Related]
25. Metabolomics profile in acute respiratory distress syndrome by nuclear magnetic resonance spectroscopy in patients with community-acquired pneumonia.
Yan Y; Chen J; Liang Q; Zheng H; Ye Y; Nan W; Zhang X; Gao H; Li Y
Respir Res; 2022 Jun; 23(1):172. PubMed ID: 35761396
[TBL] [Abstract][Full Text] [Related]
26. Metabolic signatures of hepatolithiasis using ultra-high performance liquid chromatography-tandem mass spectrometry.
Wang C; Yang J; Li E; Luo S; Sun C; Liao Y; Li M; Ge J; Lei J; Zhou F; Wu L; Liao W
Metabolomics; 2022 Aug; 18(9):69. PubMed ID: 35976530
[TBL] [Abstract][Full Text] [Related]
27. Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Shimada S; Morozumi K; Sato M; Kawamorita N; Yamashita S; Mitsuzuka K; Mano N; Ito A
Cancer Sci; 2020 Jul; 111(7):2570-2578. PubMed ID: 32350988
[TBL] [Abstract][Full Text] [Related]
28. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
29. Liquid Chromatography-Mass Spectrometry-Based Metabolomics of Nonhuman Primates after 4 Gy Total Body Radiation Exposure: Global Effects and Targeted Panels.
Pannkuk EL; Laiakis EC; Gill K; Jain SK; Mehta KY; Nishita D; Bujold K; Bakke J; Gahagen J; Authier S; Chang P; Fornace AJ
J Proteome Res; 2019 May; 18(5):2260-2269. PubMed ID: 30843397
[TBL] [Abstract][Full Text] [Related]
30. Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia.
Yang QJ; Zhao JR; Hao J; Li B; Huo Y; Han YL; Wan LL; Li J; Huang J; Lu J; Yang GJ; Guo C
J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):71-85. PubMed ID: 29152916
[TBL] [Abstract][Full Text] [Related]
31. Discovery of metabolomic biomarkers for discriminating platinum-sensitive and platinum-resistant ovarian cancer by using GC-MS.
Eroglu EC; Tunug S; Geckil OF; Gulec UK; Vardar MA; Paydas S
Eur J Mass Spectrom (Chichester); 2021 Dec; 27(6):235-248. PubMed ID: 34806450
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
33. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
34. Use of ultra high performance liquid chromatography with high resolution mass spectrometry to analyze urinary metabolome alterations following acute kidney injury in post-cardiac surgery patients.
Bai Y; Zhang H; Wu Z; Huang S; Luo Z; Wu K; Hu L; Chen C
J Mass Spectrom Adv Clin Lab; 2022 Apr; 24():31-40. PubMed ID: 35252948
[TBL] [Abstract][Full Text] [Related]
35. Application of Ion Chromatography Coupled with Mass Spectrometry for Human Serum and Urine Metabolomics.
Sun Y; Saito K; Iiji R; Saito Y
SLAS Discov; 2019 Aug; 24(7):778-786. PubMed ID: 31166806
[TBL] [Abstract][Full Text] [Related]
36. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
37. Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer.
Yi R; Xie L; Wang X; Shen C; Chen X; Qiao L
Front Oncol; 2022; 12():861142. PubMed ID: 35574395
[TBL] [Abstract][Full Text] [Related]
38. [Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry].
Ma Z; Li Z; Wang H; Wang R; Han X
Se Pu; 2022 Jun; 40(6):541-546. PubMed ID: 35616199
[TBL] [Abstract][Full Text] [Related]
39. A serum lipidomics study for the identification of specific biomarkers for endometrial polyps to distinguish them from endometrial cancer or hyperplasia.
Yan X; Zhao W; Wei J; Yao Y; Sun G; Wang L; Zhang W; Chen S; Zhou W; Zhao H; Li X; Xiao Y; Li Y
Int J Cancer; 2022 May; 150(9):1549-1559. PubMed ID: 35076938
[TBL] [Abstract][Full Text] [Related]
40.
Ye W; Lin Y; Bezabeh T; Ma C; Liang J; Zhao J; Ouyang T; Tang W; Wu R
NMR Biomed; 2021 Jun; 34(6):e4505. PubMed ID: 33783927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
